WWOX and cancer: We also noted that established mouse KO MEFs and Wwox-deficient normal breast cells responded to IR or cisplatin exposure similarly to human cancer cells, and showed resistance to killing relative to WT MEFs and Wwox-proficient breast cells, respectively [6,7].